載入...
Maintenance of Remission with Etanercept–DMARD Combination Therapy Compared with DMARDs Alone in African and Middle Eastern Patients with Active Rheumatoid Arthritis
INTRODUCTION: To compare etanercept (ETN) and placebo (PBO) for maintaining low disease activity (LDA) achieved with ETN in patients with rheumatoid arthritis (RA) from Africa and the Middle East. METHODS: In this subset analysis of the Treat-to-Target trial (ClinicalTrials.gov identifier NCT0198147...
Na minha lista:
| 發表在: | Rheumatol Ther |
|---|---|
| Main Authors: | , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Springer Healthcare
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5935625/ https://ncbi.nlm.nih.gov/pubmed/29480357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-018-0094-6 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|